T. Rowe Price Investment Management’s Avanos Medical AVNS Stock Holding History

T. Rowe Price Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$74.7M	Buy	5,330,776 +860,154	+19%	+$11.6M	0.05%	292
2025 Q4	$50.2M	Sell	4,470,622 -242,872	-5%	-$2.78M	0.03%	364
2025 Q3	$54.5M	Buy	4,713,494 +716,976	+18%	+$8.4M	0.03%	376
2025 Q2	$48.9M	Buy	3,996,518 +238,942	+6%	+$3M	0.03%	397
2025 Q1	$53.8M	Buy	3,757,576 +746,264	+25%	+$11.7M	0.04%	380
2024 Q4	$47.9M	Buy	3,011,312 +644,267	+27%	+$12.8M	0.03%	411
2024 Q3	$56.9M	Buy	2,367,045 +149,252	+7%	+$3.41M	0.03%	387
2024 Q2	$44.2M	Buy	2,217,793 +291,026	+15%	+$5.67M	0.03%	402
2024 Q1	$38.4M	Buy	1,926,767 +70,899	+4%	+$1.37M	0.02%	435
2023 Q4	$41.6M	Buy	1,855,868 +228,785	+14%	+$4.72M	0.03%	408
2023 Q3	$32.9M	Buy	1,627,083 +117,901	+8%	+$2.67M	0.02%	422
2023 Q2	$38.6M	Buy	1,509,182 +270,471	+22%	+$7.12M	0.03%	408
2023 Q1	$36.8M	Buy	+1,238,711	New	+$36M	0.03%	404

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

BCM

Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

T. Rowe Price Investment Management's AVNS Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its Avanos Medical (AVNS) stake by 19% in Q1 2026, buying an estimated $11.6M and bringing the position to 5,330,776 shares worth $74.7M. The position accounts for 0.05% of the portfolio, ranked #292.

T. Rowe Price Investment Management first reported a position in AVNS in Q1 2023 and has held it in 13 quarters since. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

T. Rowe Price Investment Management held 5,330,776 shares of Avanos Medical worth $74.7M as of Q1 2026.
T. Rowe Price Investment Management bought 860,154 Avanos Medical shares in Q1 2026, an estimated $11.6M.
Avanos Medical made up 0.05% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #292 holding.
T. Rowe Price Investment Management first reported a position in Avanos Medical in Q1 2023 and has held it in 13 quarters since.
257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.